Abbott Laboratories News

Company Name Stock Ticker Symbol Market Type
Abbott Laboratories ABT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.95 -0.86% 109.60 09:45:17
Open Price Low Price High Price Close Price Prev Close
110.93 109.475 110.93 110.55
more quote information »

Recent News

Date Time Source Heading
8/18/20227:12IHNWFeaturedElectromedical Technologies Announces Financial and Operational Highlights for the Three and Six Months Ended June 30, 2022
8/11/202209:00PRNUSNew Study Shows Abbott's Blood Test for Concussion Could..
8/04/202216:10PRNUSAbbott and WeightWatchers Partner to Support People Living..
8/03/202212:28EDGARStatement of Changes in Beneficial Ownership (4)
8/02/202216:04EDGARQuarterly Report (10-q)
7/27/202217:44EDGARStatement of Changes in Beneficial Ownership (4)
7/27/202212:49TRMNAbbott Labs (ABT) Receives a Buy from UBS
7/26/202208:00PRNCAAbbott présente la clinique virtuelle NeuroSphereMC, la..
7/21/202208:36TRMNMorgan Stanley Maintains Their Buy Rating on Abbott Labs..
7/20/202211:27TRMNAbbott Posts Q2 Beat & Raises EPS Guidance
7/20/202208:45DJNAbbott Labs Raises FY22 Earnings Guidance
7/20/202208:32DJNAbbott Labs Posts Higher 2Q Profit, Sales
7/20/202207:37EDGARCurrent Report Filing (8-k)
7/20/202207:30PRNUSAbbott Reports Second-Quarter 2022 Results and Raises..
7/12/202209:49DJNAbbott Gets FDA Breakthrough Designation to Explore Use of..
7/12/202209:00PRNUSAbbott Receives FDA's Breakthrough Device Designation to..
7/11/202209:58TRMNAbbott’s Sturgis Facility Restarts Operations
7/01/202216:35EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202216:33EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202216:29EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202216:25EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202209:00PRNUSAbbott Hosts Conference Call for Second-Quarter Earnings
6/27/202210:07DJNFDA Secures More Baby Formula
6/26/202203:37TRMNBTIG Sticks to Its Buy Rating for Abbott Labs (ABT)
6/23/202208:24TRMNIs There Any End in Sight to the Abbott Baby Formula..
6/10/202211:26PRNUSAbbott Declares 394th Consecutive Quarterly Dividend
6/09/202211:12TRMNWhy Are Abbott Shares Trending 20% Lower?
6/07/202217:17EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202205:55TRMNAbbott Restarts Michigan Baby Formula Plant; Street Says Buy
6/05/202209:00PRNUSLate-Breaking Data Demonstrate Abbott's FreeStyle Libre® 3..
6/03/202212:26DJNFDA to Allow Import of 1.3M Cans of Gerber Baby Formula..
6/03/202209:00PRNUSAbbott Announces Development of Novel Continuous..
6/02/202211:43DJNFDA Expecting 250,000 Cans of Nestle Baby Formula in June,..
5/31/202209:40TRMNBTIG Reaffirms Their Buy Rating on Abbott Labs (ABT)
5/31/202209:15DJNAbbott's FreeStyle Libre 3 for Diabetes Gets FDA Clearance
5/31/202208:00PRNUSAbbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance -..
5/27/202216:22EDGARSpecialized Disclosure Report (sd)
5/26/202207:50TRMNSafety Lapses at Abbott Exposes FDA’s Incompetence
5/25/202208:21BNZGMorning Brief: Top Financial Stories Dominating on..
5/24/202217:11PRNUSAbbott to Release EleCare® Amino Acid-based Formulas to Help..
5/23/202208:10BNZGMorning Brief: Top Financial Stories Dominating on Monday,..
5/19/202209:15PRNUSNew Late-Breaking Data Highlight Abbott Structural Heart..
5/17/202211:05DJNAbbott Laboratories on Pace for Largest Percent Increase..
5/16/202218:00DJNCorrection to Abbott Labs Enters Into Consent Decree with..
5/16/202217:10DJNAbbott Labs Enters Into Consent Decree with FDA For Michigan..
5/16/202216:22PRNUSAbbott Enters into Consent Decree with U.S. Food and Drug..
5/12/202208:34TRMNHow Will Baby Formula Shortage Affect Abbott?
5/11/202209:00PRNUSAbbott and Women as One Partner to Help More..
5/05/202218:17EDGARStatement of Changes in Beneficial Ownership (4)
5/05/202217:22EDGARStatement of Changes in Beneficial Ownership (4)

Your Recent History
Abbott Lab..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now